Mild Hypofractionation using Proton Therapy or IMRT for Low- and Intermediate-Risk Prostate Cancer

Mild Hypofractionation using Proton Therapy or IMRT for Low- and Intermediate-Risk Prostate Cancer

Brief description of study

This is a study to first establish feasibility of the study and then to register the treatment data of adult patients with a diagnosis of low or intermediate risk of prostate cancer presenting for definitive radiation treatment with either proton radiotherapy or IMRT. We propose to employ a hypofractionated strategy with our image guided treatment to further improve cancer control and decrease toxicity.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    prostate cancer
  • Age: - 99 Years
  • Gender: All
Updated on 01 Nov 2019. Study ID: 810313

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center